SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-22-001602
Filing Date
2022-11-23
Accepted
2022-11-23 10:13:27
Documents
1
Period of Report
2022-11-22

Document Format Files

Seq Description Document Type Size
1 e618054_4-vitt.html 4  
1 e618054_4-vitt.xml 4 3520
  Complete submission text file 0001193805-22-001602.txt   4972
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address IMMUNIC AG AM KLOPFERSPITZ 19 MARTINSRIED 2M 82152
Business Address
Vitt Daniel (Reporting) CIK: 0001773673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 221413386